Nobuyo Maeda

28.3k citations

265 papers · 22.1k indexed · 9 hit papers · h-index 72

Impact in

Immunology top 0.2%
- Atherosclerosis and Cardiovascular Diseases
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Biochemistry top 0.1%

Papers in

Biochemistry 26
Immunology 65
- Atherosclerosis and Cardiovascular Diseases 26
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 17

Co-authors: Oliver Smithies Robert L. Reddick Sunny H. Zhang Jorge A. Piedrahita Yasuaki Aratani William A. Kuziel J. Charles Jennette Tracey C. Dawson
Journals: Arteriosclerosis Thrombosis and Vascular Biology (19 papers)Journal of Biological Chemistry (16 papers)Journal of Clinical Investigation (16 papers)Proceedings of the National Academy of Sciences (14 papers)Journal of Lipid Research (10 papers)
Partner nations: United States Japan France

In The Last Decade

Nobuyo Maeda

257 papers receiving 21.7k citations

Hit Papers

9 papers align trajectories log scale

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice 2002 · 689 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Journal of Clinical Investigation
2002 Journal of Clinical Investigation
2001 Journal of Clinical Investigation
1997 Proceedings of the National Academy of Sciences
1997 Proceedings of the National Academy of Sciences
1996 Proceedings of the National Academy of Sciences
1992 Science
1987 Nature
1986 Annual Review of Genetics

Peers

Countries citing papers authored by Nobuyo Maeda

Since Specialization

Citations

This map shows the geographic impact of Nobuyo Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyo Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyo Maeda more than expected).

Fields of papers citing papers by Nobuyo Maeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyo Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyo Maeda. The network helps show where Nobuyo Maeda may publish in the future.

Co-authors

The 25 scholars most cited alongside Nobuyo Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nobuyo Maeda Line = papers co-authored together Nobuyo Maeda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TIMP3 promotes the maintenance of neural stem-progenitor cells in the mouse subventricular zone Frontiers in Neuroscience ·Lingyan Fang, Takaaki Kuniya, Yujin Harada, Osamu Yasuda, Nobuyo Maeda, Yutaka Suzuki, Daichi Kawaguchi, Yukiko Gotoh	2023	5
2	Cyclophilin B control of lysine post-translational modifications of skin type I collagen PLoS Genetics ·Masahiko Terajima, Yuki Taga, Wayne A. Cabral, Ying Liu, Masako Nagasawa, Noriko Sumida, Yukako Kayashima, Prashant Chandrasekaran, Lin Han, Nobuyo Maeda, Irina Perdivara, Shunji Hattori, Joan C. Marini, Mitsuo Yamauchi	2019	20
3	Role of Glycosyltransferase 25 Domain 1 in Type I Collagen Glycosylation and Molecular Phenotypes Biochemistry ·Masahiko Terajima, Yuki Taga, Marnisa Sricholpech, Yukako Kayashima, Noriko Sumida, Nobuyo Maeda, Shunji Hattori, Mitsuo Yamauchi	2019	16
4	Identification of Aortic Arch-Specific Quantitative Trait Loci for Atherosclerosis by an Intercross of DBA/2J and 129S6 Apolipoprotein E-Deficient Mice PLoS ONE ·Yukako Kayashima, Natalia Makhanova, Kota Matsuki, Hirofumi Tomita, Brian J. Bennett, Nobuyo Maeda	2015	17
5	Quantitative Trait Loci Affecting Atherosclerosis at the Aortic Root Identified in an Intercross between DBA2J and 129S6 Apolipoprotein E-Null Mice PLoS ONE ·Yukako Kayashima, Hirofumi Tomita, Svetlana Zhilicheva, Shinja Kim, Hyung‐Suk Kim, Brian J. Bennett, Nobuyo Maeda	2014	13
6	Diuretics Prevent Thiazolidinedione-Induced Cardiac Hypertrophy without Compromising Insulin-Sensitizing Effects in Mice American Journal Of Pathology ·Cherng-Shyang Chang, Pei-Jane Tsai, Junne‐Ming Sung, Ju Yi Chen, Li-Chun Ho, Kumar Pandya, Nobuyo Maeda, Yau Sheng Tsai	2013	14
7	Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction American Journal of Physiology-Heart and Circulatory Physiology ·Vijay Kandalam, Ratnadeep Basu, Thomas Abraham, Xiuhua Wang, Ahmed Awad, Wei Wang, Gary D. Lopaschuk, Nobuyo Maeda, Gavin Y. Oudit, Zamaneh Kassiri	2010	67
8	Interference With PPARγ Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling Hypertension ·Andreas Beyer, Gary L. Baumbach, Carmen M. Halabi, Mary L. Modrick, Cynthia Lynch, Thomas D. Gerhold, Shams Ghoneim, Willem J. de Lange, Henry L. Keen, Yau-Sheng Tsai, Nobuyo Maeda, Curt D. Sigmund, Frank M. Faraci	2008	95
9	Tissue‐specific regulation of ACE/ACE2 and AT₁/AT₂ receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor‐α knock‐out mice Experimental Physiology ·K. Bridget Brosnihan, Jeffrey B. Hodgin, Oliver Smithies, Nobuyo Maeda, Patricia E. Gallagher	2008	78
10	Tissue Inhibitor of Metalloproteinase-3 Deficiency Inhibits Blood Pressure Elevation and Myocardial Microvascular Remodeling Induced by Chronic Administration of N.OMEGA.-Nitro-L-Arginine Methyl Ester in Mice Hypertension Research ·Masayoshi Higuchi, Osamu Yasuda, Hidenobu Kawamoto, Takamori Yotsui, Yoshichika Baba, Tohru Ozaki, Nobuyo Maeda, Keisuke Fukuo, Hiromi Rakugi, Toshio Ogihara	2007	19
11	ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE2 mice Journal of Lipid Research* ·Myron E. Hinsdale, Patrick M. Sullivan, Hafid Mezdour, Nobuyo Maeda	2002	7
12	Using PAC nested deletions to order contigs and microsatellite markers at the high repetitive sequence containing Npr3 gene locus Gene ·Rodney C. Gilmore, Joseph Baker, Sean Dempsey, Rosemarie Marchan, Robert N.L Corprew, Goldie S. Byrd, Nobuyo Maeda, Oliver Smithies, Richard D. Bukoski, Ken R. Harewood, Pradeep K. Chatterjee	2001	14
13	Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice Journal of Clinical Investigation ·Jeffrey B. Hodgin, John H. Krege, Robert L. Reddick, Kenneth S. Korach, Oliver Smithies, Nobuyo Maeda	2001	194
14	Regional difference of lipid distribution in brain of apolipoprotein E deficient mice The Anatomical Record ·Masao Mato, Shigeo Ookawara, Toshihiro Mashiko, Atsushi Sakamoto, Takashi Mato, Nobuyo Maeda, Tatsuhiko Kodama	1999	13
15	Severe Impairment in Early Host Defense againstCandida albicansin Mice Deficient in Myeloperoxidase Infection and Immunity ·Yasuaki Aratani, Hidenori Koyama, Sei-ichiro Nyui, Kazuo Suzuki, Fumiaki Kura, Nobuyo Maeda	1999	262
16	Markedly Reduced Bile Acid Synthesis but Maintained Levels of Cholesterol and Vitamin D Metabolites in Mice with Disrupted Sterol 27-Hydroxylase Gene Journal of Biological Chemistry ·Haim Rosen, Ayeleth Reshef, Nobuyo Maeda, Andrea Lippoldt, Shoshi Shpizen, Liat Triger, Gösta Eggertsen, Ingemar Björkhem, Eran Leitersdorf	1998	196
17	Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2 Proceedings of the National Academy of Sciences ·William A. Kuziel, Sharon J. Morgan, Tracey C. Dawson, Stephanie Griffin, Oliver Smithies, Klaus Ley, Nobuyo Maeda Hit paper breakdown →	1997	573
18	A New Family of Retroviral Long Terminal Repeat Elements in the Human Genome Identified by Their Homologies to an Element 5′ to the Spider Monkey Haptoglobin Gene Genomics ·Laurie Erickson, Nobuyo Maeda	1995	4
19	Junctions between genes in the haptoglobin gene cluster of primates Genomics ·Laurie Erickson, Hyung‐Suk Kim, Nobuyo Maeda	1992	22
20	Targetted correction of a mutant HPRT gene in mouse embryonic stem cells Nature ·Thomas Doetschman, Ronald G. Gregg, Nobuyo Maeda, Martin Hooper, David W. Melton, Simon Thompson, Oliver Smithies Hit paper breakdown →	1987	550

About Nobuyo Maeda

Nobuyo Maeda is a scholar working on Biochemistry, Immunology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology, having authored 265 papers that have together received 22.1k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (38 papers), Cholesterol and Lipid Metabolism (32 papers), Atherosclerosis and Cardiovascular Diseases (26 papers), Renin-Angiotensin System Studies (20 papers), Adipose Tissue and Metabolism (19 papers), Nitric Oxide and Endothelin Effects (19 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers). The work is most often cited by research in Immunology (4.8k citations), Biochemistry (1.6k citations), Physiology (4.0k citations), Endocrinology, Diabetes and Metabolism (2.5k citations) and Cardiology and Cardiovascular Medicine (3.0k citations). Nobuyo Maeda has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Oliver Smithies, Robert L. Reddick, Sunny H. Zhang, Jorge A. Piedrahita, Yasuaki Aratani, William A. Kuziel, J. Charles Jennette, Tracey C. Dawson, Hyung‐Suk Kim and Ronald J. Falk. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact